Allogeneic WTX-212C in Advanced Solid Tumors

NCT07556653 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

NOT_YET_RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: allogeneic WTX-212C

Sponsor

Zhejiang Provincial People's Hospital

Collaborators

[object Object]
[object Object]